Valeant (VRX): Pearson Recently Exercised Options, Required to Hold 1M Shares for 2 Years
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells Fargo
July 14, 2016 1:29 PM EDTWhile Valeant Pharmaceuticals (NYSE: VRX) continues to avoid trading on fundamentals three potential catalysts lie ahead for the company. Today, Wells Fargo bearish-leaning analyst David Maris provide his thoughts ahead of these events.
The 3 events are:
Friday (7/15) advisory panel documents should become available ahead of next Tuesdays (7/19) FDA advisory panel on brodalumab;next... MoreValeant Pharma (VRX) Shares Rise After Clarifying Recent Pearson Stock, Options Sales
July 14, 2016 9:00 AM EDTValeant Pharma (NYSE: VRX) shares are indicated higher in early trading Thursday after the company issued commentary on recent stock transactions conducted by former CEO Mike Pearson. The stock is up over 3 percent.
... MoreHave Valeant Pharma (VRX) Shareholders Finally Capitulated?
July 13, 2016 12:24 PM EDTValeant Pharma (NYSE: VRX) is gaining as earlier reported liquidation at Sequoia Fund and news that ex-CEO... More
Valeant Pharma (VRX) Pearson Said to Have Sold 5M Shares - CNBC
July 13, 2016 11:28 AM EDTCNBC Scott Wapner reports Valeant Pharma (NYSE: VRX) Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m.
... More
